Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-26 07:08 am Sale |
2023-04-17 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% |
-857,844 (Position Closed) |
Filing History |
| 2023-02-14 11:48 am Purchase |
2022-12-31 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 488,367 9.990% |
488,367 (New Position) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Calithera Biosciences, Inc. CALA |
Citadel Advisors LLC | 249,336 5.100% |
249,336 (New Position) |
Filing History |
| 2023-02-09 4:02 pm Purchase |
2022-12-31 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO/CA/ | 401,080 8.240% |
201,117 (+100.58%) |
Filing History |
| 2023-02-09 4:01 pm Sale |
2023-01-31 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO/CA/ | 199,963 4.110% |
-206,317 (-50.78%) |
Filing History |
| 2023-02-08 4:05 pm Sale |
2023-01-13 | 13G | Calithera Biosciences, Inc. CALA |
INCYTE CORP INCY |
0 0.000% |
-86,022 (Position Closed) |
Filing History |
| 2022-12-08 11:49 am Purchase |
2022-11-30 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO/CA/ | 406,280 8.350% |
406,280 (New Position) |
Filing History |
| 2022-07-06 06:12 am Purchase |
2022-07-01 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 857,844 15.000% |
116,970 (+15.79%) |
Filing History |
| 2022-04-21 06:06 am Purchase |
2021-10-18 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 740,874 13.200% |
740,874 (New Position) |
Filing History |
| 2022-04-11 4:03 pm Purchase |
2022-03-30 | 13G | Calithera Biosciences, Inc. CALA |
Citadel Advisors LLC | 251,754 5.400% |
70,226 (+38.69%) |
Filing History |
| 2022-02-14 06:26 am Sale |
2021-12-31 | 13G | Calithera Biosciences, Inc. CALA |
Citadel Advisors LLC | 181,527 4.800% |
-2,680 (-1.45%) |
Filing History |
| 2022-02-10 12:22 pm Purchase |
2021-12-31 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO/CA/ | 536,650 14.320% |
23,975 (+4.68%) |
Filing History |
| 2022-02-10 09:12 am Sale |
2021-12-31 | 13G | Calithera Biosciences, Inc. CALA |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-200,000 (Position Closed) |
Filing History |
| 2022-02-09 3:33 pm Sale |
2021-12-31 | 13G | Calithera Biosciences, Inc. CALA |
The Vanguard Group | 143,080 3.820% |
-40,655 (-22.13%) |
Filing History |
| 2021-12-10 1:13 pm Sale |
2021-11-30 | 13G | Calithera Biosciences, Inc. CALA |
FEDERATED HERMES INC. FHI |
71 0.000% |
-372,059 (-99.98%) |
Filing History |
| 2021-11-22 4:05 pm Purchase |
2021-11-10 | 13G | Calithera Biosciences, Inc. CALA |
Citadel Advisors LLC | 184,207 4.900% |
184,207 (New Position) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Calithera Biosciences, Inc. CALA |
BlackRock Inc. BLK |
139,805 3.800% |
-143,615 (-50.67%) |
Filing History |
| 2021-07-08 5:00 pm Purchase |
2021-07-06 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 372,617 10.100% |
154,555 (+70.88%) |
Filing History |
| 2021-02-16 3:32 pm Sale |
2020-12-31 | 13G | Calithera Biosciences, Inc. CALA |
Point72 Asset Management, L.P. | 86,718 2.500% |
-75,284 (-46.47%) |
Filing History |
| 2021-02-12 1:18 pm Purchase |
2020-12-31 | 13G | Calithera Biosciences, Inc. CALA |
FEDERATED HERMES INC. FHI |
372,130 10.550% |
25,400 (+7.33%) |
Filing History |